Information Sheets

FDA's Role_ ClinicalTrials.gov Information _ FDA.pdf

FDA Use of Investigational Products When Subjects Enter a Second Institution _ FDA.pdf

FDA-Inspections-of-Clinical-Investigators---Information-Sheet.pdf

FDA Sponsor - Investigator - IRB Interrelationship _ FDA.pdf

FDA Waiver-of-IRB-Requirements-for-Drug-and-Biological-Product-Studies---Information-Sheet.pdf

FDA-Institutional-Review-Board-Inspections---Information-Sheet.pdf

FDA Significant-Risk-and-Nonsignificant-Risk-Medical-Device-Studies---Information-Sheet.pdf

FDA Screening Tests Prior to Study Enrollment _ FDA.pdf

FDA Payment and Reimbursement to Research Subjects _ FDA.pdf

FDA Recruiting Study Subjects _ FDA.pdf

FDA Institutional Review Boards Frequently Asked Questions _ FDA.pdf

FDA Information Sheet Guidance for Sponsors, Clinical Investigators, and IRBs Frequently Asked Questions Statement of Investigator.pdf

FDA Non-local IRB Review _ FDA.pdf

FDA Cooperative Research _ FDA.pdf

FDA Artificial Intelligence for Drug Development _ FDA.pdf

FDA Evaluation of Sex Differences in Clinical Investigations _ FDA.pdf

FDA Emergency Use of an Investigational Drug or Biologic _ FDA.pdf

Institutional Review Boards Frequently Asked Questions _ FDA.pdf

Page updated

Google Sites

Report abuse